Literature DB >> 17063281

Infliximab-associated neuropathy in RA patients--the importance of considering the diagnosis of mononeuritis multiplex.

J Birnbaum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17063281     DOI: 10.1007/s10067-006-0436-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  8 in total

1.  "Pseudo-conduction block" in a patient with vasculitic neuropathy.

Authors:  F Sandbrink; A D Klion; M K Floeter
Journal:  Electromyogr Clin Neurophysiol       Date:  2001-06

2.  Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy.

Authors:  C Rodriguez-Escalera; J Belzunegui; L Lopez-Dominguez; C Gonzalez; M Figueroa
Journal:  Rheumatology (Oxford)       Date:  2005-01       Impact factor: 7.580

3.  Acute neuropathy with multiple conduction blocks after TNFalpha monoclonal antibody therapy.

Authors:  Oliver C Singer; Bettina Otto; Helmuth Steinmetz; Ulf Ziemann
Journal:  Neurology       Date:  2004-11-09       Impact factor: 9.910

Review 4.  Multifocal motor neuropathy.

Authors:  Jan-Thies H Van Asseldonk; Hessel Franssen; Renske M Van den Berg-Vos; John H J Wokke; Leonard H Van den Berg
Journal:  Lancet Neurol       Date:  2005-05       Impact factor: 44.182

5.  Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment.

Authors:  Maria G Tektonidou; John Serelis; Fotini N Skopouli
Journal:  Clin Rheumatol       Date:  2006-07-06       Impact factor: 2.980

6.  "Pseudo-conduction block" in vasculitic neuropathy.

Authors:  L McCluskey; D Feinberg; C Cantor; S Bird
Journal:  Muscle Nerve       Date:  1999-10       Impact factor: 3.217

7.  Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis.

Authors:  Pascal Richette; Philippe Dieudé; Joël Damiano; Frédéric Lioté; Philippe Orcel; Thomas Bardin
Journal:  J Rheumatol       Date:  2004-10       Impact factor: 4.666

8.  Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series.

Authors:  Stephen J Jarrett; Gaye Cunnane; Philip G Conaghan; Sarah J Bingham; Maya H Buch; Mark A Quinn; Paul Emery
Journal:  J Rheumatol       Date:  2003-10       Impact factor: 4.666

  8 in total
  4 in total

1.  A case of spontaneously recovering multifocal motor neuropathy with conduction blocks (MMNCB) during anti-TNF alpha therapy for ankylosing spondylitis.

Authors:  Giuseppe Paolazzi; Susanna Peccatori; Francesco P Cavatorta; Alberto Morini
Journal:  Clin Rheumatol       Date:  2009-04-07       Impact factor: 2.980

Review 2.  Monoclonal antibody therapy-associated neurological disorders.

Authors:  Xavier Bosch; Albert Saiz; Manuel Ramos-Casals
Journal:  Nat Rev Neurol       Date:  2011-01-25       Impact factor: 42.937

Review 3.  Update on medication-induced peripheral neuropathy.

Authors:  Louis H Weimer; Noor Sachdev
Journal:  Curr Neurol Neurosci Rep       Date:  2009-01       Impact factor: 5.081

4.  Effect of tumor necrosis factor inhibitors on rheumatoid arthritis-induced peripheral neuropathy: A cohort study.

Authors:  Naizhi Wang; Yingying Guo; Lili Yang; Wenyi Fu; Yanbing Xu; Linxin Hou; Shuai Zhao; Ning Zhang
Journal:  Neural Regen Res       Date:  2012-04-15       Impact factor: 5.135

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.